Aflac Inc.

Aflac trades at a surprisingly defensive 15.9 P/E despite sitting well below its 52-week high, suggesting the market hasn't fully re-rated this accident & health insurer even as valuations compress. With RSI at 49.5, the stock occupies neutral technical territory—neither oversold nor overbought—while a modest 2.05% short float indicates minimal squeeze potential. The combination of modest valuation, absence of extreme bearish positioning, and middling momentum readings paints a picture of a stalwart dividend player caught between institutional indifference and fundamental stability, lacking the catalysts needed to reignite meaningful upside momentum from current levels.